Try the modernized ClinicalTrials.gov beta website. Learn more about the modernization effort.
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Evaluation of the Interest of a Specialist in Dermatology for Dermatopediatric Consultations (HLSkinPed)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03578718
Recruitment Status : Unknown
Verified June 2018 by Central Hospital, Nancy, France.
Recruitment status was:  Not yet recruiting
First Posted : July 6, 2018
Last Update Posted : July 6, 2018
Sponsor:
Information provided by (Responsible Party):
Central Hospital, Nancy, France

Study Description
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information
Brief Summary:

Dermatologic diseases, of very different etiology and variable severity, represent a major motivation for consultation (in private consultations and in emergency departments), thus leading pediatricians to frequently turn to dermatologic advice.

The principal aim is to estimate the degree of concordance of the main diagnosis between a pediatrician and a pediatric dermatologist.

The secondary aims is to estimate the degree of concordance of the treatment, advices and follow-up.


Condition or disease
Dermatologic Disease Pediatric ALL Collaboration

Study Design
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Layout table for study information
Study Type : Observational
Estimated Enrollment : 100 participants
Observational Model: Cohort
Time Perspective: Prospective
Official Title: Evaluation of the Interest of a Specialist in Dermatology for Dermatopediatric Consultations
Estimated Study Start Date : June 25, 2018
Estimated Primary Completion Date : May 1, 2019
Estimated Study Completion Date : May 1, 2019

Resource links provided by the National Library of Medicine


Groups and Cohorts
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information


Outcome Measures
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Primary Outcome Measures :
  1. principal diagnosis [ Time Frame: baseline ]
    % of concordance between diagnosis (dermatologist/pediatric)


Secondary Outcome Measures :
  1. treament [ Time Frame: baseline ]
    % of concordance between treatment (dermatologist/pediatric)

  2. advices [ Time Frame: baseline ]
    % of concordance between advices(dermatologist/pediatric)

  3. follow-up [ Time Frame: baseline ]
    % of concordance between follow-up (dermatologist/pediatric)


Eligibility Criteria
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   up to 18 Years   (Child, Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
all patients Under 18 years old consulting for a dermatological problem in emergency department or in a private pediatric consultation
Criteria

Inclusion Criteria:

  • Under 18 years old
  • consultating for dermatologic problem in emergency department (1 department) or private pediatric center (1 center)
  • signed consent
  • consécutives consultations

Exclusion Criteria:

  • no consent
Contacts and Locations
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03578718


Contacts
Layout table for location contacts
Contact: BURSZTEJN Anne Calire, MCU-PH +3383157153 ac.bursztejn@chru-nancy.fr

Sponsors and Collaborators
Central Hospital, Nancy, France
More Information
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information
Layout table for additonal information
Responsible Party: Central Hospital, Nancy, France
ClinicalTrials.gov Identifier: NCT03578718    
Other Study ID Numbers: 2018-A00088-47
First Posted: July 6, 2018    Key Record Dates
Last Update Posted: July 6, 2018
Last Verified: June 2018

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Additional relevant MeSH terms:
Layout table for MeSH terms
Skin Diseases